Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 May;35(5):455–459. doi: 10.1111/j.1365-2125.1993.tb04169.x

Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study.

A G Johnson 1, L A Simons 1, J Simons 1, Y Friedlander 1, J McCallum 1
PMCID: PMC1381681  PMID: 8512757

Abstract

1. Whether non-steroidal anti-inflammatory drug (NSAID) usage in the elderly elevates blood pressure or antagonises the blood pressure-lowering effect of antihypertensive medication is presently unknown. The primary aims of this study were to estimate the prevalence of NSAID usage, to evaluate the prescription of NSAIDs for arthritis and to determine whether NSAID usage was an independent predictor of hypertension in a large elderly community. 2. All non-institutionalised elderly (> 60 years) residents of Dubbo, NSW who attended for a baseline assessment were enrolled (1237 males, 1568 females). A questionnaire was administered and blood pressure was measured according to the Prineas protocol. The frequency of NSAID usage was determined, with stratification by age, sex, blood pressure group and history of arthritis. 3. NSAID usage was 26% overall (females 28%, males 23%), increased with age and was higher in females than males for every age group studied. Amongst patients with a past history of 'arthritis', 45% were using NSAIDs. Twelve percent were taking NSAIDs and antihypertensive medication concurrently, constituting the population at risk of an adverse drug-drug interaction. Employing a multiple logistic regression model which adjusted for several confounders in the cross-sectional analysis, NSAID usage significantly predicted the presence of hypertension (odds ratio: 1.4, 95% confidence interval: 1.1-1.7) with an attributable risk of 29%. 4. Amongst non-institutionalised elderly persons, NSAID usage may be an independent risk factor for hypertension. Considering the substantial consumption of NSAIDs by elderly patients, physicians should review their NSAID prescribing patterns for this community group.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., Hansson L., Andrén L., Gudbrandsson T., Sivertsson R., Svensson A. Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. Acta Med Scand. 1981;210(3):221–229. [PubMed] [Google Scholar]
  2. Armstrong C. P., Blower A. L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987 May;28(5):527–532. doi: 10.1136/gut.28.5.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baskin S. I., Smith L., Hoey L. A., Levy P. I., Goldfarb A. H. Age-associated changes of responses to acetylsalicylic acid. Pain. 1981 Aug;11(1):1–8. doi: 10.1016/0304-3959(81)90134-2. [DOI] [PubMed] [Google Scholar]
  4. Blackshear J. L., Davidman M., Stillman M. T. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1983 Jun;143(6):1130–1134. [PubMed] [Google Scholar]
  5. Bradley J. D., Brandt K. D., Katz B. P., Kalasinski L. A., Ryan S. I. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991 Jul 11;325(2):87–91. doi: 10.1056/NEJM199107113250203. [DOI] [PubMed] [Google Scholar]
  6. Broadhurst P., Hughes L. O., Raftery E. B. Non-invasive ambulatory blood pressure monitors: a cautionary note. J Hypertens. 1990 Jul;8(7):595–597. doi: 10.1097/00004872-199007000-00002. [DOI] [PubMed] [Google Scholar]
  7. Chalmers J. P., West M. J., Wing L. M., Bune A. J., Graham J. R. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. Clin Exp Hypertens A. 1984;6(6):1077–1093. doi: 10.3109/10641968409039582. [DOI] [PubMed] [Google Scholar]
  8. Davidson R. A., Hale W. E., Moore M. T., May F. E., Marks R. G., Stewart R. B. Incidence of hypertension in an ambulatory elderly population. J Am Geriatr Soc. 1989 Sep;37(9):861–866. doi: 10.1111/j.1532-5415.1989.tb02267.x. [DOI] [PubMed] [Google Scholar]
  9. Gerber J. G., LoVerde M., Byyny R. L., Nies A. S. The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent. Clin Pharmacol Ther. 1990 Oct;48(4):424–430. doi: 10.1038/clpt.1990.171. [DOI] [PubMed] [Google Scholar]
  10. Guess H. A., West R., Strand L. M., Helston D., Lydick E. G., Bergman U., Wolski K. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol. 1988;41(1):35–45. doi: 10.1016/0895-4356(88)90007-8. [DOI] [PubMed] [Google Scholar]
  11. Hardy B. G., Bartle W. R., Myers M., Bailey D. G., Edgar B. Effect of indomethacin on the pharmacokinetics and pharmacodynamics of felodipine. Br J Clin Pharmacol. 1988 Nov;26(5):557–562. doi: 10.1111/j.1365-2125.1988.tb05295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Henry D. A. Side-effects of non-steroidal anti-inflammatory drugs. Baillieres Clin Rheumatol. 1988 Aug;2(2):425–454. doi: 10.1016/s0950-3579(88)80021-9. [DOI] [PubMed] [Google Scholar]
  13. Hurwitz N., Wade O. L. Intensive hospital monitoring of adverse reactions to drugs. Br Med J. 1969 Mar 1;1(5643):531–536. doi: 10.1136/bmj.1.5643.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Inman W. H. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J. 1977 Jun 11;1(6075):1500–1505. doi: 10.1136/bmj.1.6075.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kannel W. B., Dawber T. R., Sorlie P., Wolf P. A. Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham study. Stroke. 1976 Jul-Aug;7(4):327–331. doi: 10.1161/01.str.7.4.327. [DOI] [PubMed] [Google Scholar]
  16. Kannel W. B., Wolf P. A., Verter J., McNamara P. M. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA. 1970 Oct 12;214(2):301–310. [PubMed] [Google Scholar]
  17. Langman M. J. Anti-inflammatory drug intake and the risk of ulcer complications. Med Toxicol. 1986;1 (Suppl 1):34–38. [PubMed] [Google Scholar]
  18. Magarò M., Altomonte L., Zoli A., Mirone L., Berchicci M. C., Tricerri A., Corvino G. Asymptomatic and symptomatic gastroduodenal patients affected by rheumatic disease treated with non-steroidal anti-inflammatory drugs. Panminerva Med. 1989 Jan-Mar;31(1):16–18. [PubMed] [Google Scholar]
  19. Miller R. R. Drug surveillance utilizing epidemiologic methods. A report from the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm. 1973 Jul;30(7):584–592. [PubMed] [Google Scholar]
  20. O'Brien W. M., Bagby G. F. Rare adverse reactions to nonsteroidal antiinflammatory drugs. 4. J Rheumatol. 1985 Aug;12(4):785–790. [PubMed] [Google Scholar]
  21. Pedrinelli R., Magagna A., Salvetti A. The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet. Eur J Clin Invest. 1982 Apr;12(2):107–111. doi: 10.1111/j.1365-2362.1982.tb00946.x. [DOI] [PubMed] [Google Scholar]
  22. Simons L. A., McCallum J., Friedlander Y., Simons J., Powell I., Heller R. Dubbo study of the elderly: sociological and cardiovascular risk factors at entry. Aust N Z J Med. 1991 Oct;21(5):701–709. doi: 10.1111/j.1445-5994.1991.tb01373.x. [DOI] [PubMed] [Google Scholar]
  23. Simons L. A., McCallum J., Simons J., Powell I., Ruys J., Heller R., Lerba C. The Dubbo study: an Australian prospective community study of the health of elderly. Aust N Z J Med. 1990 Dec;20(6):783–789. doi: 10.1111/j.1445-5994.1990.tb00423.x. [DOI] [PubMed] [Google Scholar]
  24. Simons L. A., Simons J., McCallum J., Friedlander Y. Dubbo Study of the elderly: hypertension and lipid levels. Atherosclerosis. 1992 Jan;92(1):59–65. doi: 10.1016/0021-9150(92)90010-e. [DOI] [PubMed] [Google Scholar]
  25. Steele K., Mills K. A., Gilliland A. E., Irwin W. G., Taggart A. Repeat prescribing of non-steroidal anti-inflammatory drugs excluding aspirin: how careful are we? Br Med J (Clin Res Ed) 1987 Oct 17;295(6604):962–964. doi: 10.1136/bmj.295.6604.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Walt R., Katschinski B., Logan R., Ashley J., Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet. 1986 Mar 1;1(8479):489–492. doi: 10.1016/s0140-6736(86)92940-5. [DOI] [PubMed] [Google Scholar]
  27. Wong D. G., Spence J. D., Lamki L., Freeman D., McDonald J. W. Effect of non-steroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. Lancet. 1986 May 3;1(8488):997–1001. doi: 10.1016/s0140-6736(86)91271-7. [DOI] [PubMed] [Google Scholar]
  28. Wright J. T., McKenney J. M., Lehany A. M., Bryan D. L., Cooper L. W., Lambert C. M. The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide. Clin Pharmacol Ther. 1989 Oct;46(4):440–444. doi: 10.1038/clpt.1989.162. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES